ArticleCancer medicine2026
Development and Feasibility Evaluation of a Nurse-Led ePRO System for Home-Based Post-Chemotherapy Symptom Management in Patients With Cancer.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundElectronic patient-reported outcome (ePRO) systems support symptom monitoring after chemotherapy; however, their integration into structured nurse-led oncology workflows remains limited. In this study, we aimed to develop and evaluate the short-term feasibility and usability of a nurse-led ePRO system for home-based postchemotherapy symptom monitoring and structured nursing triage for cancer patients.
methodsThis single-arm feasibility study was conducted at a cancer center in Taiwan between April and September 2024 among adult patients requiring home-based symptom monitoring after hospital-based chemotherapy care. The nurse-led digital system was designed to support weekly self-reporting of 12 chemotherapy-related symptoms using the Chemotherapy Toxicity Self-Assessment Questionnaire. The system incorporated rule-based triage categorization using green, orange, and red risk levels and predefined nurse response protocols. Feasibility outcomes included report adherence, triage alert management, and system performance. Usability was evaluated using the System Usability Scale.
resultsForty-two patients submitted 306 symptom reports during the 8-week monitoring period, corresponding to an overall adherence rate of 91.1%. Among all reports, 16.3% generated orange alerts requiring nurse follow-up and 6.5% generated red alerts requiring urgent review. Fatigue, pain, and hand-foot syndrome were the most frequently reported abnormal symptoms. All orange and red alerts had documented nursing review. The system met the predefined technical performance indicators during simulated load testing, and achieved a mean System Usability Scale score of 92.6 ± 6.46.
conclusionsThis nurse-led ePRO system demonstrated favorable short-term feasibility and usability for home-based postchemotherapy symptom monitoring and structured nursing triage. These findings support the practicality of integrating structured ePRO monitoring into postchemotherapy nursing care. Further multicenter and comparative studies are warranted to evaluate long-term engagement, scalability, and clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.